Apyx Medical (APYX) Free Cash Flow (2011 - 2026)
Apyx Medical (APYX) posted Free Cash Flow of -$632000.0 for Q1 2026, up 77.46% on a QoQ basis from -$2.8 million in Q4 2025, and up 16.51% year-over-year from -$542430.8 in Q1 2025.
Apyx Medical (APYX) Free Cash Flow (2011 - 2026) Analysis & Trends
Apyx Medical's Free Cash Flow history runs 16 years deep, the most recent figure standing at -$632000.0 for Q1 2026.
- Quarterly Free Cash Flow rose 16.51% year-over-year to -$632000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.0 million (up 31.64% YoY) and the FY2025 annual result came in at -$9.1 million, up 51.44% from the prior year.
- Free Cash Flow was -$632000.0 for Q1 2026 at Apyx Medical, up from -$2.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $3.5 million in Q3 2023 and bottomed at -$6.4 million in Q1 2024.
- A 5-year average of -$3.3 million and a median of -$4.1 million in 2025 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 3859.32% — and 2023, when it soared 163.48%.
- Apyx Medical's Free Cash Flow stood at -$4.7 million in 2022, then surged by 50.66% to -$2.3 million in 2023, then sank by 38.05% to -$3.2 million in 2024, then climbed by 11.88% to -$2.8 million in 2025, then soared by 77.46% to -$632000.0 in 2026.
- Business Quant data shows APYX's Free Cash Flow at -$632000.0 in Q1 2026, -$2.8 million in Q4 2025, and -$4.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.90 Bn | 176.61 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 128.85 Bn | 125.97 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 108.77 Bn | 99.55 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 48.50 Bn | 44.83 Bn | 1.29 Bn | -21.10 Mn |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.08 Bn | 1.98 Bn | 112.00 Mn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 449.00 Mn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.35 Bn | 2.07 Bn | 305.56 Mn |
| 10 | Apyx Medical | 172.78 Mn | 141.64 Mn | 7.93 Mn | -632,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -632,000.00 |
| Mar 31, 2026 | -632,000.00 |
| Dec 31, 2025 | -2.80 Mn |
| Dec 31, 2025 | -2.80 Mn |
| Sep 30, 2025 | -4.06 Mn |
| Sep 30, 2025 | -4.06 Mn |
| Jun 30, 2025 | -1.50 Mn |
| Jun 30, 2025 | -1.50 Mn |
| Mar 31, 2025 | -757,000.00 |
| Mar 31, 2025 | -757,000.00 |
| Dec 31, 2024 | -3.18 Mn |
| Dec 31, 2024 | -3.18 Mn |
| Sep 30, 2024 | -4.59 Mn |
| Sep 30, 2024 | -4.59 Mn |
| Jun 30, 2024 | -4.62 Mn |
| Jun 30, 2024 | -4.62 Mn |
| Mar 31, 2024 | -6.38 Mn |
| Mar 31, 2024 | -6.38 Mn |
| Dec 31, 2023 | -2.31 Mn |
| Dec 31, 2023 | -2.31 Mn |